Asia Pacific Antacids Market Size, Share & Industry Trends Analysis Report By Formulation Type (Tablets, Liquids and Others), By Mechanism of Action (Non-systemic and Systemic), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

The Asia Pacific Antacids Market would witness market growth of 3.9% CAGR during the forecast period (2023-2029).

Gastroenterologists and general practitioners face a special problem when treating the elderly population because of acid issues. Additionally, esophageal cancer and Barrett's esophagus are common symptoms in these patients. Antacid use in such circumstances has expanded dramatically. Such illnesses are treated with a combination of therapies, and this trend is expected to continue. The need for antacids is also being driven by e-commerce, which is causing a sharp increase in the number of online retail outlets. As a result, the rise in e-commerce and the number of online medical professionals are helping to fuel the market's expansion.

The only antacid forms previously accessible were pills, liquids, and powders. However, researchers have recently created a mouth-melting antacid that is made of microgranule that melt quickly in the mouth. Utilizing cutting-edge melting technology, these granules combine the therapeutic properties of herbal ingredients. As a result, an emerging trend in the antacid market known as mouth-watering antacids is anticipated to offer an attractive possibility for market expansion throughout the forecast period.

In 2005–2006, 13% of women and 9% of males between 15 and 49 ages were overweight or obese, according to the National Family Health Survey India–3 (NFHS–3). The prevalence of obesity was higher in urban areas in comparison to rural areas and was lower among individuals who worked in manual or agricultural activities. Overeating is the main factor that contributes to obesity. When food intake outpaces energy use, the body begins to store fat, which leads to obesity. Over time, overweight and obese people develop from consuming more calories than they can burn. One of the main reasons why people get obese is a change in lifestyle. Therefore, the market will experience significant growth in the region.

The China market dominated the Asia Pacific Antacids Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $622.4 Million by 2029. The Japan market is estimated to grow a CAGR of 3.3% during (2023 - 2029). Additionally, The India market would experience a CAGR of 4.5% during (2023 - 2029).

Based on Formulation Type, the market is segmented into Tablets, Liquids and Others. Based on Mechanism of Action, the market is segmented into Non-systemic and Systemic. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Antacids Market is Projected to reach USD 7.9 Billion by 2029, at a CAGR of 3.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Alkem Laboratories Ltd., Bayer AG, Cipla Limited, Pfizer, Inc., Prestige Consumer Healthcare, Inc., Reckitt Benckiser Group PLC, WellSpring Pharmaceutical Corporation (Avista Capital Partners), Sanofi S.A. and Sun Pharmaceutical Industries Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Formulation Type

• Tablets
• Liquids
• Others

By Mechanism of Action

• Non-systemic
• Systemic

By Distribution Channel

• Drug Store & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Alkem Laboratories Ltd.
• Bayer AG
• Cipla Limited
• Pfizer, Inc.
• Prestige Consumer Healthcare, Inc.
• Reckitt Benckiser Group PLC
• WellSpring Pharmaceutical Corporation (Avista Capital Partners)
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Antacids Market, by Formulation Type
1.4.2 Asia Pacific Antacids Market, by Mechanism of Action
1.4.3 Asia Pacific Antacids Market, by Distribution Channel
1.4.4 Asia Pacific Antacids Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Antacids Market by Formulation Type
3.1 Asia Pacific Tablets Market by Country
3.2 Asia Pacific Liquids Market by Country
3.3 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Antacids Market by Mechanism of Action
4.1 Asia Pacific Non-systemic Market by Country
4.2 Asia Pacific Systemic Market by Country

Chapter 5. Asia Pacific Antacids Market by Distribution Channel
5.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
5.2 Asia Pacific Hospital Pharmacies Market by Country
5.3 Asia Pacific Online Pharmacies Market by Country

Chapter 6. Asia Pacific Antacids Market by Country
6.1 China Antacids Market
6.1.1 China Antacids Market by Formulation Type
6.1.2 China Antacids Market by Mechanism of Action
6.1.3 China Antacids Market by Distribution Channel
6.2 Japan Antacids Market
6.2.1 Japan Antacids Market by Formulation Type
6.2.2 Japan Antacids Market by Mechanism of Action
6.2.3 Japan Antacids Market by Distribution Channel
6.3 India Antacids Market
6.3.1 India Antacids Market by Formulation Type
6.3.2 India Antacids Market by Mechanism of Action
6.3.3 India Antacids Market by Distribution Channel
6.4 South Korea Antacids Market
6.4.1 South Korea Antacids Market by Formulation Type
6.4.2 South Korea Antacids Market by Mechanism of Action
6.4.3 South Korea Antacids Market by Distribution Channel
6.5 Singapore Antacids Market
6.5.1 Singapore Antacids Market by Formulation Type
6.5.2 Singapore Antacids Market by Mechanism of Action
6.5.3 Singapore Antacids Market by Distribution Channel
6.6 Malaysia Antacids Market
6.6.1 Malaysia Antacids Market by Formulation Type
6.6.2 Malaysia Antacids Market by Mechanism of Action
6.6.3 Malaysia Antacids Market by Distribution Channel
6.7 Rest of Asia Pacific Antacids Market
6.7.1 Rest of Asia Pacific Antacids Market by Formulation Type
6.7.2 Rest of Asia Pacific Antacids Market by Mechanism of Action
6.7.3 Rest of Asia Pacific Antacids Market by Distribution Channel

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Alkem Laboratories Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Bayer AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Cipla Limited
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expense
7.6 Prestige Consumer Healthcare, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.7 Reckitt Benckiser Group PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 WellSpring Pharmaceutical Corporation (Avista Capital Partners)
7.8.1 Company Overview
7.9 Sanofi S.A.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Sun Pharmaceutical Industries Ltd.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses

TABLE 1 Asia Pacific Antacids Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Antacids Market, 2023 - 2029, USD Million
TABLE 3 Asia Pacific Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 5 Asia Pacific Tablets Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Tablets Market by Country, 2023 - 2029, USD Million
TABLE 7 Asia Pacific Liquids Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Liquids Market by Country, 2023 - 2029, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 11 Asia Pacific Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 13 Asia Pacific Non-systemic Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Non-systemic Market by Country, 2023 - 2029, USD Million
TABLE 15 Asia Pacific Systemic Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Systemic Market by Country, 2023 - 2029, USD Million
TABLE 17 Asia Pacific Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 21 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 23 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 Asia Pacific Antacids Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Antacids Market by Country, 2023 - 2029, USD Million
TABLE 27 China Antacids Market, 2019 - 2022, USD Million
TABLE 28 China Antacids Market, 2023 - 2029, USD Million
TABLE 29 China Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 30 China Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 31 China Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 32 China Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 33 China Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 China Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 Japan Antacids Market, 2019 - 2022, USD Million
TABLE 36 Japan Antacids Market, 2023 - 2029, USD Million
TABLE 37 Japan Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 38 Japan Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 39 Japan Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 40 Japan Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 41 Japan Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Japan Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 India Antacids Market, 2019 - 2022, USD Million
TABLE 44 India Antacids Market, 2023 - 2029, USD Million
TABLE 45 India Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 46 India Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 47 India Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 48 India Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 49 India Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 India Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 South Korea Antacids Market, 2019 - 2022, USD Million
TABLE 52 South Korea Antacids Market, 2023 - 2029, USD Million
TABLE 53 South Korea Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 54 South Korea Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 55 South Korea Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 56 South Korea Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 57 South Korea Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 South Korea Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 Singapore Antacids Market, 2019 - 2022, USD Million
TABLE 60 Singapore Antacids Market, 2023 - 2029, USD Million
TABLE 61 Singapore Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 62 Singapore Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 63 Singapore Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 64 Singapore Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 65 Singapore Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Singapore Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 67 Malaysia Antacids Market, 2019 - 2022, USD Million
TABLE 68 Malaysia Antacids Market, 2023 - 2029, USD Million
TABLE 69 Malaysia Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 70 Malaysia Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 71 Malaysia Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 72 Malaysia Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 73 Malaysia Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Malaysia Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 75 Rest of Asia Pacific Antacids Market, 2019 - 2022, USD Million
TABLE 76 Rest of Asia Pacific Antacids Market, 2023 - 2029, USD Million
TABLE 77 Rest of Asia Pacific Antacids Market by Formulation Type, 2019 - 2022, USD Million
TABLE 78 Rest of Asia Pacific Antacids Market by Formulation Type, 2023 - 2029, USD Million
TABLE 79 Rest of Asia Pacific Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 80 Rest of Asia Pacific Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 81 Rest of Asia Pacific Antacids Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Antacids Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 83 Key Information – Abbott Laboratories
TABLE 84 Key Information – Alkem Laboratories Ltd.
TABLE 85 Key Information – Bayer AG
TABLE 86 Key Information – Cipla Limited
TABLE 87 Key Information – Pfizer, Inc.
TABLE 88 Key Information – Prestige Consumer Healthcare, Inc.
TABLE 89 Key information – Reckitt Benckiser Group PLC
TABLE 90 Key Information – WellSpring Pharmaceutical Corporation
TABLE 91 Key Information – Sanofi S.A.
TABLE 92 Key Information – Sun Pharmaceutical Industries Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Antacids Market share by Formulation Type, 2022
FIG 3 Asia Pacific Antacids Market share by Formulation Type, 2029
FIG 4 Asia Pacific Antacids Market by Formulation Type, 2019 - 2029, USD Million
FIG 5 Asia Pacific Antacids Market share by Mechanism of Action, 2022
FIG 6 Asia Pacific Antacids Market share by Mechanism of Action, 2029
FIG 7 Asia Pacific Antacids Market by Mechanism of Action, 2019 - 2029, USD Million
FIG 8 Asia Pacific Antacids Market share by Distribution Channel, 2022
FIG 9 Asia Pacific Antacids Market share by Distribution Channel, 2029
FIG 10 Asia Pacific Antacids Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 Asia Pacific Antacids Market share by Country, 2022
FIG 12 Asia Pacific Antacids Market share by Country, 2029
FIG 13 Asia Pacific Antacids Market by Country, 2019 - 2029, USD Million
FIG 14 Swot analysis: Abbott laboratories
FIG 15 Swot analysis: bayer ag